Rosa Saltarelli

500 total citations
9 papers, 356 citations indexed

About

Rosa Saltarelli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Rosa Saltarelli has authored 9 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 2 papers in Epidemiology. Recurrent topics in Rosa Saltarelli's work include Cancer Treatment and Pharmacology (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Rosa Saltarelli is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Rosa Saltarelli collaborates with scholars based in Italy, Slovakia and United States. Rosa Saltarelli's co-authors include Enrico Cortesi, Giuseppe Naso, Bruno Vincenzi, Paola Gazzaniga, Angela Gradilone, Cristina Raimondi, Arianna Petracca, Antonella Palazzo, Chiara Nicolazzo and Orietta Gandini and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Breast Cancer Research and Treatment.

In The Last Decade

Rosa Saltarelli

8 papers receiving 346 citations

Peers

Rosa Saltarelli

ONCOL

PRM

Sara Jansson Sweden

Annkathrin Hanssen Germany

Paymaneh D. Malihi United States

Santino Minichillo Italy

Cecilie Bendigtsen Schirmer Norway

Rachel Krupa United States

Gabriel Abril-Rodríguez United States

Rachel Payne United Kingdom

Paul Winograd United States

Joseph E. Grossman United States

Sara Jansson Sweden

Rosa Saltarelli

374 ×1.2

ONCOL

209 ×1.1

92 ×0.8

PRM

132 ×1.7

51 ×1.0

Citations per year, relative to Rosa Saltarelli Rosa Saltarelli (= 1×) peers Sara Jansson

Countries citing papers authored by Rosa Saltarelli

Since Specialization

Citations

This map shows the geographic impact of Rosa Saltarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Saltarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Saltarelli more than expected).

Fields of papers citing papers by Rosa Saltarelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Saltarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Saltarelli. The network helps show where Rosa Saltarelli may publish in the future.

Co-authorship network of co-authors of Rosa Saltarelli

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Saltarelli. A scholar is included among the top collaborators of Rosa Saltarelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Saltarelli. Rosa Saltarelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Basso, Michele, Carlo Signorelli, Maria Alessandra Calegari, et al.. (2024). Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis. Targeted Oncology. 19(3). 371–382. 1 indexed citations

Signorelli, Carlo, Marta Schirripa, Mario Giovanni Chilelli, et al.. (2023). Sequential treatment with regorafenib and trifluridine/tipiracil in later-line refractory metastatic colorectal cancer: A real-world multicenter retrospective study.. Journal of Clinical Oncology. 41(4_suppl). 45–45.

Signorelli, Carlo, Roberta Grande, Salvatore De Marco, et al.. (2021). Regorafenib-to-trifluridine/tipiracil Versus the Reverse Sequence for Refractory Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Real-life Experience. Anticancer Research. 41(5). 2553–2561. 1 indexed citations

Raimondi, Cristina, Angela Gradilone, Giuseppe Naso, et al.. (2011). Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Research and Treatment. 130(2). 449–455. 211 indexed citations

Gradilone, Angela, Giuseppe Naso, Cristina Raimondi, et al.. (2010). Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. Annals of Oncology. 22(1). 86–92. 109 indexed citations

Nelli, Fabrizio, Giuseppe Naso, Rosa Saltarelli, et al.. (2004). Weekly Vinorelbine and Docetaxel as Second-Line Chemotherapy for Pretreated Non-Small Cell Lung Cancer Patients: a Phase I-II Trial. Journal of Chemotherapy. 16(4). 392–399. 12 indexed citations

Fabi, Alessandra, Virginia Ferraresi, Enrico Cortesi, et al.. (2004). The combination of carboplatin and weekly paclitaxel: a safe and active regimen in advanced non small-cell lung cancer patients. A phase I-II study.. PubMed. 23(1). 25–32. 5 indexed citations

Moscetti, Luca, et al.. (2003). P-23 The combination of gemcitabine (G) and cisplatin (P) in the general population of elderly patients with advanced NSCLC. Lung Cancer. 41. S96–S97. 2 indexed citations

Moscetti, Luca, Rosa Saltarelli, Rosa Giuliani, et al.. (2000). Intra-Arterial Liver Chemotherapy and Hormone Therapy in Malignant Insulinoma: Case Report and Review of the Literature. Tumori Journal. 86(6). 475–479. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact